FDA Approved: AMBRISENTAN — Supplemental Application (Zydus Lifesciences Limited)

View source ↗

Summary

FDA approves a supplemental application for AMBRISENTAN by Zydus Lifesciences Limited, resulting in approval of a generic ambrisentan product. The approval supp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• Ambrisentan (Ambrisentan)

Snippet

SUPPL AP for AMBRISENTAN (AMBRISENTAN)